Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis

NCT02201043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Thalidomide 150mg
DRUG: Thalidomide 100mg
DRUG: Placebo

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd